MedPath

To assess the combined effect of Virechana, Pratisarana and Gandoosha in Periodontitis.

Phase 3
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2022/01/039130
Lead Sponsor
Amrita School of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of age 20-60years

Chronicity less than 5years

Minimum of 3 sites with >=4mm pocket depth

Minimum of 3 sites that bleed on probing

Patients who have not received any periodontal therapies during past 6 months

Exclusion Criteria

Patients suffering from known systemic diseases like diabetes, cardiovascular, kidney disorders, Atherosclerosis.

Patients having alveolar destruction

Pregnant or lactating females

Immunocompromised patient, smokers, alcoholics

Patients who received any chemotherapeutic medicines during past 6 months

Patients who are contraindicated for virechana and gandoosha

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the combined effect of virechana, pratisarana, gandusha in improving the symptoms, gingival bleeding index and plaque index in periodontitis. <br/ ><br> <br/ ><br>Restoration of normal microbial profile of saliva in periodontitis <br/ ><br>Timepoint: Subjective parameters, plaque and Gingival bleeding index score will be analysed at baseline visit, on 45th day (AT) and on each follow up visit (75th, 105th and 135th day). <br/ ><br> <br/ ><br> <br/ ><br>Saliva pH and microbial load will be assessed at time of baseline visit and on 45th day(AT). <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To understand the effectiveness of the treatment trial in preventing the recurrence of periodontitis.Timepoint: 75th, 105th and 135th day after completion of treatment trial.
© Copyright 2025. All Rights Reserved by MedPath